StratDeck

Two stocks in Healthcare

Johnson & Johnson vs Stryker: profit, growth, debt and price compared

Johnson & Johnson is stronger on 4 of 7 figures: profit margin, debt, dividend and price trend. Stryker is stronger on 2: sales growth and price for its expected profit.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Johnson & Johnson's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Johnson & Johnson and Stryker side by side
Johnson & JohnsonJNJStrykerSYK
Net marginStronger: 16.2%13.8%
Revenue growth, past year+5.86%Stronger: +7.64%
Debt to equityStronger: 54.8%65.8%
Forward P/E23.5×Stronger: 19.5×
Dividend yieldStronger: 1.94%1.11%
AnalystsBuy · 22Buy · 27
From its 200-day averageStronger: +10.2%−0.2%

Share price over the past year

  • Johnson & Johnson+36.3%
  • Stryker−11.5%

18 Nov 202518 Nov 2026

Johnson & Johnson or Stryker: which is stronger?

  • JNJ

    Which is more profitable?

    Johnson & Johnson keeps more of each sale as profit: 16.2% against 13.8%.

  • SYK

    Which is growing its sales faster?

    Stryker is growing its sales faster: +7.64% over the past year, against +5.86%.

  • JNJ

    Which has borrowed less?

    Johnson & Johnson has borrowed less: its debt is 54.8% of what its shareholders own, against 65.8% for Stryker.

  • SYK

    Which costs less for the profit it is expected to make?

    Stryker costs less for the profit it is expected to make: 19.5× its forward earnings, against 23.5×.

  • JNJ

    Which pays more in dividends?

    Johnson & Johnson pays more back in dividends for what a share costs: 1.94% a year, against 1.11%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • JNJ

    Which is in the stronger price trend?

    Johnson & Johnson's price is in the stronger trend: 10.2% above its 200-day average, against 0.2% below.

What each company does

JNJJohnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Reports results on 26 January 2027

SYKStryker

Stryker Corporation operates as a medical technology company in the United States and internationally.

Reports results on 28 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.